Understanding the relationship between pharmaceutical manufacturers and payers in 2022

In this webinar recording, Amplity's Cheryl Nagowski and Dan Cusack walk participants through the current thinking around payer price sensitivities. This session explores why manufacturers are beginning to roll the dice with their pre-commercial assets and step away from the payer table. 

Watch now for our take on this new market access paradigm as you prepare your commercialization strategy for 2022 and beyond

By watching this webinar, you will learn:

• Payer negotiation opening stance
• What’s happening with the 6mo PBM NDC block upon launch
• Why it’s about the rebate and not the price

 

WATCH NOW

Ready to talk Market Access strategy?

Click here to set up a meeting with the speakers of this webinar, Cheryl and Dan.